1. Removing barriers to accessing medical cannabis for paediatric patients
- Author
-
Richard J Huntsman, Jesse Elliott, Evan Lewis, Charlotte Moore-Hepburn, Jane Alcorn, Holly Mansell, Juan P Appendino, Richard E Bélanger, Scott Corley, Bruce Crooks, Anne Marie M Denny, Yaron Finkelstein, Allen Finley, Ryan Fung, Andrea Gilpin, Catherine Litalien, Julia Jacobs, Timothy F Oberlander, Ashley Palm, Jacob Palm, Monika Polewicz, Declan Quinn, S Rod Rassekh, Alexander Repetski, Michael J Rieder, Amy Robson-McKay, Blair Seifert, Alan Shackelford, Hal Siden, Michael Szafron, Geert ‘t Jong, Régis Vaillancourt, and Lauren E Kelly
- Subjects
Pediatrics, Perinatology and Child Health - Abstract
Medical cannabis (MC) may offer therapeutic benefits for children with complex neurological conditions and chronic diseases. In Canada, parents, and caregivers frequently report encountering barriers when accessing MC for their children. These include negative preconceived notions about risks and benefits, challenges connecting with a knowledgeable healthcare provider (HCP), the high cost of MC products, and navigating MC product shortages. In this manuscript, we explore several of these barriers and provide recommendations to decision-makers to enable a family-centered and evidence-based approach to MC medicine and research for children.
- Published
- 2023